Xiaojian Zhu

First Affiliated Hospital of Jiangxi Medical College — China

Medicine · Health Sciences

21h-index1.5kcitations108works5.52yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

CAR-T cell therapy research(46), Chronic Myeloid Leukemia Treatments(18), Immune Cell Function and Interaction(15), Acute Myeloid Leukemia Research(13), Virus-based gene therapy research(13)

Publications108 total

Gut microbiota-derived butyrate orchestrates Astragalus Polysaccharide-mediated colitis remission via macrophage immunometabolic reprogramming
2026Open Access
HNRNPC reprograms cancer metabolism to drive acquired chemoresistance in colorectal cancer by repressing of Nrf2/SLC7A11-dependent ferroptosis
Cell Communication and Signaling·2025Open Access
Prognostic value of BTG1 for predicting decitabine sensitivity in de novo acute myeloid leukemia
iScience·2025Open Access
Mesenchymal Stromal Cells: Bridging the Gaps in Hematologic Disease Therapy
Stem Cell Reviews and Reports·2025Open Access
Effectiveness and safety of axicabtagene ciloleucel (Axi-cel) in Chinese patients with relapsed/refractory non-Hodgkin lymphoma: Age subgroup analysis of real-world study
Blood·2025
Long-term Therapy Outcomes of CD19/22 CAR T Cell Alone or with Autologous Stem Cell Transplantation for Relapsed/Refractory DLBCL
Blood Cancer Discovery·2025· 1 cited
CD70-targeted CAR-T/NK therapy: Rationale, advances, and future directions
Translational Oncology·2025· 4 citedOpen Access
Fatal complication unveiled: analyzing intracerebral hemorrhage risk after CAR-T therapy in hematologic malignancies
Brain Hemorrhages·2025Open Access
Efficacy and safety of a novel CD19, CD22 dual-targeted fully human loop bi-CAR-T for the treatment of relapsed/refractory B cell non-Hodgkin lymphoma
Journal of Translational Medicine·2025· 6 citedOpen Access
Targeting intracellular LMP2 with costimulatory signal–armed antibody-like TCR T cells
JCI Insight·2025· 4 citedOpen Access
HNRNPC stabilizes m6A-modified AC145207.5 to accelerate tumorigenesis in colorectal cancer by impeding the Nrf2/GPX4 axis-mediated ferroptosis
Non-coding RNA Research·2025· 2 citedOpen Access
Immune‐Related Adverse Events in a Patient With Burkitt’s Lymphoma During PD‐1 Immune Consolidation Therapy: A Case Report
Case Reports in Hematology·2025Open Access
HNRNPC stabilizes m6A-modified AC145207.5 to accelerate tumorigenesis in colorectal cancer by impeding the Nrf2/GPX4 axis-mediated ferroptosis
2024Open Access
Advances in CAR-T therapy for central nervous system tumors
Biomarker Research·2024· 16 citedOpen Access
Efficacy and Safety of Axicabtagene Ciloleucel (Axi-cel) for the Treatment of Relapse/Refractory Non-Hodgkin's Lymphoma: Real-World Data in Chinese Population
Blood·2024
Efficacy of Decitabine in Combination with IA Versus IA in Patients with Newly Diagnosed AML, a Multicenter, Prospective, Randomized Controlled Trial
Blood·2024
Correction: Anti-CD5 CAR-T cells with a tEGFR safety switch exhibit potent toxicity control
Blood Cancer Journal·2024· 1 citedOpen Access
CAR-T cell combination therapies in hematologic malignancies
Experimental Hematology and Oncology·2024· 23 citedOpen Access
Hereditary thrombotic thrombocytopenic purpura associated with recurrent strokes and prominent nervous system involvement in a young Chinese female
2024Open Access
Advances in second hematopoietic stem cell transplantation
Frontiers in Immunology·2024· 1 citedOpen Access
page 1 of 6Next →

Frequent Co-authors

Zhaodong Zhong(13), Ping Zou(13), Jue Wang(11), Yong You(11), An‐Yuan Guo(10), Fankai Meng(10), Jianfeng Zhou(9), Liang Huang(8), Yi Xiao(8), Zhichao Chen(6), Qing Li(6), Yang Cao(6), Yicheng Zhang(6), Fanjun Cheng(5), Hongxiang Wang(5), Xiaoying Zhu(5), Na Wang(5), Songya Liu(5), Qing Li(4), Qiubai Li(4)